hero section gradient
10 handpicked stocks

Invest Like the Wealthiest

These carefully selected stocks represent the cornerstone holdings of the world's richest billionaires. Our team of analysts has curated this collection based on the Bloomberg Billionaires Index to help you invest alongside proven wealth creators.

Author avatar

Han Tan | Market Analyst

Published on May 11

Your Basket's Financial Footprint

Market capitalisation breakdown for the 'Invest Like the Wealthiest' basket, showing total market cap and component sizes.

Key Takeaways for Investors:
  • Large-cap dominance suggests lower volatility and tends to track broad-market moves rather than idiosyncratic swings.
  • Use this basket as a core holding to provide stable equity exposure, not for speculative, short-term gains.
  • Expect steady, long-term appreciation rather than explosive short-term returns; growth is likely moderate and sustained.
Total Market Cap
  • TSLA: $1.47T

  • AMZN: $2.37T

  • META: $1.84T

  • Other

About This Group of Stocks

1

Our Expert Thinking

The world's richest people have a proven track record of growing wealth. By investing in the companies they own and control, you can benefit from their long-term vision and business acumen. These billionaires have collectively amassed over $10 trillion, more than several major economies combined.

2

What You Need to Know

This collection features stable, influential companies that form the foundation of billionaire wealth. Many are tech-focused with strong growth potential, but also includes diverse sectors like retail and finance. These stocks tend to have significant market impact and often drive broader market trends.

3

Why These Stocks

Each company in this collection was handpicked because it represents a significant portion of a top billionaire's fortune according to the Bloomberg Billionaires Index. These aren't random picks but rather the carefully selected companies that have created some of the world's largest personal fortunes.

Why You'll Want to Watch These Stocks

💰

Billionaire-Backed Power

These aren't just any companies – they've created some of the world's largest personal fortunes. Investing here means putting your money where the world's richest have built their wealth.

🚀

Record-Breaking Potential

In 2024 alone, these billionaires saw their collective wealth cross $10 trillion for the first time ever. Their companies continue to set market records and drive innovation.

🌎

World-Changing Influence

The companies in this collection have more economic power than many countries combined. Their decisions and developments shape entire industries and affect global markets.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions